Thank you, Heather. Now let's turn to our results on Slide 10. We delivered $2.18 of adjusted operating earnings per share in the second quarter compared with $2.21 a year ago. Our results reflect higher fee-based margins in Wealth and Investment Management, offset by lower underwriting in Health. We expect higher loss ratios in Health to persist this year. That said, we are actively incorporating the elevated claims data into the January 2025 pricing to return loss ratios to our target range next year. Our focus on management actions, including diligence on spend, is helping us remain on track to achieve $8.25 to $8.45 of adjusted operating EPS in 2024. Second quarter GAAP net income was $201 million compared to $154 million in the prior year quarter, due to more favorable investment gains and lower acquisition and integration costs. Excess capital generation in the quarter remains robust at approximately $200 million, consistent with our track record of generating above our 90% target. And we remain on track to generate $800 million for the full year. Turning to Wealth on Slide 11. We continue to improve outcomes and deliver value for our customers, driving growth in both assets and participants. Our participant count exceeds 7 million, representing a 6% CAGR growth since 2019. Defined contribution client assets have grown to over $519 billion as of June 30. Full Service and recordkeeping net outflows were $597 million and $1 billion, respectively, in the second quarter. While improved equity markets are a net positive for retirement, they do have a counterintuitive effect on net flows by increasing the average account values of each participant surrender even though our surrender rates have improved. We continue to retain 98% of all Full Service plans and sales are up, powered by the mid-market where sales in the quarter are 3x higher year-over-year. Looking forward, we continue to build a strong pipeline and expect positive net flows in Full Service for the second half of the year. Moving to Slide 12. Wealth generated $214 million of adjusted operating earnings in the second quarter. This was meaningfully higher than the prior year, due to strong fees and expense discipline. Net revenues were 3% higher year-over-year, driven by strong management actions and favorable markets. Fee-based revenues reflect consistent growth in our participants and strong equity markets in 2024. For spread income, our actions to drive higher margin in the current rate environment has helped to offset the effect of lower spread-based assets. The spread income guidance we have provided assume rates follow the forward curve prospectively. Our adjusted operating margin of 39.7% is an outcome of the net revenue growth and discipline on spend. The second quarter did include some timing benefits for administrative expenses, which contributes to the higher expense guidance we are providing for next quarter. We continue to be disciplined with our spend and have taken actions to further integrate our business while still investing for growth. This includes capabilities in the mid-market and Retail Wealth Management. Turning to Slide 13 on Health. Our immediate focus is to return aggregate loss ratios to within our 69% to 72% targeted range. In the second quarter, the total aggregate loss ratio was 72.9%, primarily driven by loss ratios for Stop Loss, which were above our 77% to 80% target range. While we feel good about the rate increases achieved on the non-January 2024 business, the impact on this year's results will be modest. Voya has a strong track record in Stop Loss. We also have an experienced team that helped correct the book in 2018 when our 2017 loss ratios were above target. As a result, we are confident in our ability to achieve target loss ratios in 2025. We continue to find the fundamentals of the Stop Loss business attractive as it can be repriced annually, has a natural tailwind for growth due to medical inflation and is a growing market as companies move to self-fund their employee health care plans. In-force premium growth remains robust and is supported by expanded quoting capabilities, success in the mid-market and greater adoption of voluntary solutions. Moving to Slide 14. Health adjusted operating earnings were $60 million in the second quarter. This compares to exceptionally favorable results in 2023, when loss ratios were well below target ranges. Looking ahead, we feel confident with our ability to restore loss ratios back to our target range in 2025, while continuing to profitably grow our Health business. Moving to Investment Management on Slide 15. The successful transformation of our business into a diversified global investment manager with an enhanced platform of investment solutions is allowing us to deliver strong results today and enabling opportunities to scale in new growth markets. We generated positive net inflows of $4.8 billion in the second quarter, putting us on track to meet our 2% organic growth expectation for the full year. In institutional, we saw significant improvement and a return to positive net cash flows of approximately $3 billion. This was led by strong demand for core fixed income in the insurance channel. In retail, positive net cash flows of approximately $2 billion reflect continued momentum in both U.S. and international intermediary channels, including demand for our income and growth solutions, retail private equity fund and core fixed income. As a reminder, management of the remaining legacy assets connected to our annuity divestiture in 2018 is expected to transfer to Venerable over the next 12 months starting this September. These transfers will complete the runoff of approximately $14 billion in assets under management and an additional $4 billion in assets under administration. These assets were generally in lower fee index-oriented solutions. These flows have no impact on our general account and continue to be reflected in current guidance, which remains unchanged. Our leading positions in institutional fixed income and third-party insurance asset management serve as competitive advantages, and will support continued client and asset growth. Turning to Slide 16. Investment Management delivered adjusted operating earnings of $50 million in the second quarter, net of AllianzGI's noncontrolling interest. Second quarter net revenues were 5% higher year-over-year, reflecting strong growth in intermediary and insurance assets under management and favorable equity markets. Adjusted operating margin was 26% on a trailing 12-month basis, reflecting continued expense discipline while investing for growth. We remain on track to achieve our goal of expanding operating margins by at least 100 basis points on a full year basis in 2024. We are encouraged by our commercial momentum, and we expect our diverse pipeline and strong investment performance will support our outlook for 2% organic growth for the year. Turning to Slide 17. Our strong capital generation differentiates us from peers. We continue to build on our track record of generating excess capital above 90% of earnings, while still investing for growth. In the second quarter, we returned $214 million of capital to shareholders, including $174 million of share repurchases and $40 million of dividends. As Heather mentioned, we increased our quarterly dividend by $0.05 or 12.5%. Raising the dividend is driven by confidence in our business mix and our track record of consistent high free cash generation. It is also another step to regularly grow our dividend over time. Our leverage ratio sits comfortably in our targeted range of 25% to 30% today. Looking ahead, we have $400 million of debt maturing in 2025, which we intend to refinance, subject to market conditions. Turning to Slide 18. Management actions are keeping us on track to meet our full year adjusted operating EPS target of $8.25 to $8.45. Wealth delivered strong revenue growth and profitability in the second quarter. In Health, we have a clear plan to address lower-than-expected underwriting performance. In Investment Management, we have transformed the business into a diversified global asset manager, and we remain confident in our ability to achieve 2% organic growth with expanded margins. Finally, we are on track to generate and return over $800 million of excess capital to shareholders in the form of share repurchases and dividends in 2024. With that, I will turn the call back to the operator so that we can take your questions.